These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3548121)

  • 1. [Phenotypic and genotypic marker in malignant lymphomas: cellular origin of Hodgkin's disease and malignant histiocytosis as well as implications for classifying T-cell and B-cell lymphomas].
    Stein H; Gerdes J
    Verh Dtsch Ges Pathol; 1986; 70():127-51. PubMed ID: 3548121
    [No Abstract]   [Full Text] [Related]  

  • 2. Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes.
    Spencer J; Cerf-Bensussan N; Jarry A; Brousse N; Guy-Grand D; Krajewski AS; Isaacson PG
    Am J Pathol; 1988 Jul; 132(1):1-5. PubMed ID: 3260750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
    Lauder I; Bird CC; Child JA; Grigor I
    J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against SU-DHL-1 cells stain the neoplastic cells in true histiocytic lymphoma, malignant histiocytosis, and Hodgkin's disease.
    Hsu SM; Pescovitz MD; Hsu PL
    Blood; 1986 Jul; 68(1):213-9. PubMed ID: 2424524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Tac antigen in B cell lymphomas.
    Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
    Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic expression of non-Hodgkin's lymphomas in China.
    Xu LZ; Tu LY; Liu YF; Hsu SM; Qiu BS; Li ZX
    J Natl Cancer Inst; 1984 Sep; 73(3):635-8. PubMed ID: 6236322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphomas: membrane markers and cell flow cytometric diagnosis.
    Glassman AB; Self S; Christopher J
    Ann Clin Lab Sci; 1987; 17(1):1-7. PubMed ID: 3579204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining of non-Hodgkin's lymphoma in paraffin sections using the MB1 and MT1 monoclonal antibodies.
    Dobson CM; Myskow MW; Krajewski AS; Carpenter FH; Horne CH
    J Pathol; 1987 Nov; 153(3):203-12. PubMed ID: 3323430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T-cell lymphoma].
    Hurwitz N; Vorst EJ; Evron R; Reichman N; Reznitsky P; Bassous L; Berrebi A
    Harefuah; 1990 Feb; 118(3):146-8. PubMed ID: 2341065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant histiocytosis in infants: surface marker analysis of malignant cells in two cases.
    Ishii E; Hara T; Okamura J; Suda M; Takeuchi T; Iida K; Ueda K
    Med Pediatr Oncol; 1987; 15(2):102-8. PubMed ID: 3495721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical approach to the immunodiagnosis of lymphomas emphasizing differential diagnosis.
    Warnke RA; Weiss LM
    Cancer Surv; 1985; 4(2):349-58. PubMed ID: 3879857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
    Kikuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse monoclonal antibodies against the idiotype of human B cell non-Hodgkin lymphomas: production, characterization and use to monitor the progress of disease.
    Rankin EM; Hekman A
    Eur J Immunol; 1984 Dec; 14(12):1119-26. PubMed ID: 6394351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical approach to immunophenotyping of lymphomas. Comparison of immunohistologic and immunocytologic techniques.
    Sun T; Susin M
    Ann Clin Lab Sci; 1987; 17(1):14-26. PubMed ID: 3555278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.
    Delsol G; Al Saati T; Gatter KC; Gerdes J; Schwarting R; Caveriviere P; Rigal-Huguet F; Robert A; Stein H; Mason DY
    Am J Pathol; 1988 Jan; 130(1):59-70. PubMed ID: 2827494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.